Folgen
George R Thompson
George R Thompson
Professor of Medicine, Division of Infectious Diseases, University of California - Davis
Bestätigte E-Mail-Adresse bei ucdavis.edu
Titel
Zitiert von
Zitiert von
Jahr
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
64932020
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
31592016
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
23582020
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
19372021
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
9722016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet infectious diseases 16 (7), 828-837, 2016
7212016
Coccidioidomycosis: epidemiology
J Brown, K Benedict, BJ Park, GR Thompson III
Clinical epidemiology, 185-197, 2013
3282013
The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin
M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ...
Drugs 81, 1703-1729, 2021
3152021
Oropharyngeal candidiasis in the era of antiretroviral therapy
GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2010
2432010
Aspergillosis: epidemiology, diagnosis, and treatment
J Cadena, GR Thompson, TF Patterson
Infectious Disease Clinics 35 (2), 415-434, 2021
2312021
Aspiring antifungals: review of current antifungal pipeline developments
TJ Gintjee, MA Donnelley, GR Thompson III
Journal of Fungi 6 (1), 28, 2020
2102020
Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation
G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang, I Cai, A Fenton, ...
PLoS pathogens 11 (7), e1005066, 2015
2062015
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ...
Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008
2062008
Overview of antifungal agents
GR Thompson, J Cadena, TF Patterson
Clinics in chest medicine 30 (2), 203-215, 2009
2052009
Isavuconazole treatment of cryptococcosis and dimorphic mycoses
GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ...
Reviews of Infectious Diseases 63 (3), 356-362, 2016
1972016
Valley Fever: Finding New Places for an Old Disease: Coccidioides immitis Found in Washington State Soil Associated With Recent Human Infection
AP Litvintseva, N Marsden-Haug, S Hurst, H Hill, L Gade, EM Driebe, ...
Clinical Infectious Diseases 60 (1), e1-e3, 2015
1892015
Coccidioidomycosis
NW Stockamp, GR Thompson
Infectious Disease Clinics 30 (1), 229-246, 2016
1852016
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International …
GR Thompson, T Le, A Chindamporn, CA Kauffman, ...
The Lancet Infectious Diseases 21 (12), e364-e374, 2021
1822021
Invasive aspergillosis: current strategies for diagnosis and management
J Cadena, GR Thompson, TF Patterson
Infectious Disease Clinics 30 (1), 125-142, 2016
1802016
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
BJ Kullberg, C Viscoli, PG Pappas, J Vazquez, L Ostrosky-Zeichner, ...
Clinical Infectious Diseases 68 (12), 1981-1989, 2019
1722019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20